UVA Health study shows stem cell transplants often prevent relapsing in common childhood cancers A new study out of UVA Health is giving hope to children with cancer, many of whom tend to relapse. By Riley Wyant | March 31, 2021 at 7:51 PM EDT - Updated March 31 at 9:58 PM CHARLOTTESVILLE, Va. (WVIR) - A new study out of University of Virginia Health is giving hope to children with cancer, many of whom tend to relapse. Researchers at UVA Health found that children and young adults in remission who receive CAR T-cell therapy and a subsequent stem cell transplant are not as prone to relapsing. The Journal of Clinical Oncology published the findings.